The US Retina Health Market competitiveness is intensifying as established players and emerging biotech firms race to bring novel therapies to patients. With North America commanding over 46% of global ophthalmology revenue and the US representing the largest single-country market, competitive positioning strategies are evolving rapidly. The market benefits from a well-funded research ecosystem...